Gilteritinib vs salvage chemotherapy in FLT3-mutated acute myeloid leukemia: number needed to treat for clinical outcomes per a secondary analysis of the ADMIRAL trialAmer M Zeidan,Cynthia Z Qi,Hongbo Yang,Andy Garnham,Manasee V Shah,Bhavik J PandyaLEUKEMIA & LYMPHOMA（2022）引用 1|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
